Table 3.

Risk of prostate cancer specific mortality and non-PC death based on Fine and Gray proportional hazards regression model.

PCSM
Variable	HR	95% CI	p Value
Age	0.99	0.97–1.02	0.96
African-American race (versus Caucasian)	0.53	0.27–1.07	0.08
Number of comorbidities	1.03	0.88–1.21	0.69
CAPRA score	1.27	1.17–1.37	<0.001
Treatment with RT (versus RP)	1.43	0.97–2.12	0.07
Receipt of ADT (versus no)	1.30	0.90–1.89	0.16
Non-PC Death
Variable	HR	95% CI	p Value
Age	1.06	1.05–1.08	<0.001
African-American race (versus Caucasian)	1.34	1.03–1.73	0.03
Number of comorbidities	1.23	1.15–1.32	<0.001
CAPRA score	0.99	0.96–1.04	0.98
Treatment with RT (versus RP)	1.26	1.07–1.49	0.006
Receipt of ADT (versus no)	1.22	1.03–1.44	0.02